Utama › Leukemia Limfoblastik Akut
Kajian klinikal Leukemia Limfoblastik Akut sedang mengambil peserta di AS
134 kajian untuk Leukemia Limfoblastik Akut sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Houston, TX28 kajian
- New York City, NY24 kajian
- Baldwin Park, CA21 kajian
- Seattle, WA21 kajian
- Chicago, IL19 kajian
- Atlanta, GA19 kajian
- Philadelphia, PA16 kajian
- Memphis, TN16 kajian
- Washington, DC16 kajian
- Boston, MA15 kajian
- Los Angeles, CA14 kajian
- Durham, NC13 kajian
- Mountain View, CA13 kajian
- Cincinnati, OH12 kajian
- Minneapolis, MN12 kajian
- Columbus, OH11 kajian
- Tampa, FL10 kajian
- Salt Lake City, UT10 kajian
- Portland, OR9 kajian
- Baltimore, MD9 kajian
- Miami, FL8 kajian
- Aurora, CO8 kajian
- Nashville, TN8 kajian
- San Antonio, TX8 kajian
- Charlotte, NC8 kajian
- Edison, NJ8 kajian
- Cleveland, OH7 kajian
- Birmingham, AL7 kajian
- Denver, CO7 kajian
- Pittsburgh, PA6 kajian
- Oklahoma City, OK6 kajian
- Milwaukee, WI6 kajian
- Detroit, MI6 kajian
- Phoenix, AZ6 kajian
- San Diego, CA6 kajian
- St. Louis, MO6 kajian
- Queens, NY6 kajian
- San Francisco, CA5 kajian
- Clifton, NJ5 kajian
- The Bronx, NY5 kajian
Mengikut negeri
- Alabama7 kajian
- Arizona6 kajian
- Arkansas5 kajian
- California40 kajian
- Colorado12 kajian
- Connecticut3 kajian
- Florida19 kajian
- Georgia20 kajian
- Hawaii3 kajian
- Illinois20 kajian
- Indiana6 kajian
- Iowa5 kajian
- Kansas5 kajian
- Kentucky4 kajian
- Louisiana6 kajian
- Maine3 kajian
- Maryland16 kajian
- Massachusetts15 kajian
- Michigan8 kajian
- Minnesota14 kajian
- Mississippi3 kajian
- Missouri6 kajian
- Nebraska4 kajian
- Nevada3 kajian
- New Jersey11 kajian
- New Mexico3 kajian
- New York32 kajian
- North Carolina21 kajian
- Ohio21 kajian
- Oklahoma8 kajian
- Oregon10 kajian
- Pennsylvania21 kajian
- Rhode Island3 kajian
- South Carolina5 kajian
- South Dakota3 kajian
- Tennessee22 kajian
- Texas30 kajian
- Utah10 kajian
- Virginia9 kajian
- Washington22 kajian
- West Virginia4 kajian
- Wilayah Columbia10 kajian
- Wisconsin9 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
Mengambil pesertaFasa 1
Sehingga umur 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT01853631A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
Mengambil peserta
Umur 1 hingga 25 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05621291Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Mengambil pesertaFasa 1
Umur 18 hingga 120 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06904066Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Mengambil pesertaFasa 1
Umur 18 hingga 120 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07572136Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Mengambil pesertaKajian pemerhatian
Umur 0 hingga 38 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06131801CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
Mengambil pesertaFasa 2
Umur 3 hingga 65 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07328503CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
Mengambil pesertaFasa 1/2
Umur 3 hingga 39 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT05442515A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Mengambil pesertaFasa 1
Umur 12 hingga 78 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT03802695A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Mengambil pesertaFasa 2
6 Months · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06514794Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06144606Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Mengambil pesertaFasa awal 1
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06398457Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
Mengambil pesertaKajian pemerhatian
4 Weeks – 18 Years · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06529575Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06308588Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06819475A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Mengambil pesertaFasa 1/2
30 Days · Semua jantina · Dikemas kini 16 Sep 2026 · NCT04065399A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
Mengambil pesertaFasa 1
Umur 0 hingga 18 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT06173518Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06904482Cord Blood Transplant in Adults With Blood Cancers
Mengambil pesertaFasa 2
Umur 21 hingga 65 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT05884333Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
Mengambil pesertaFasa 1/2
Umur 16 hingga 75 · Semua jantina · Dikemas kini 10 Sep 2026 · NCT03104491Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies
Mengambil pesertaFasa 1
Umur 1 hingga 25 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT06408194First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Sep 2026 · NCT07586618Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
Sehingga umur 50 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT05322850Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
Mengambil pesertaFasa 1
Sehingga umur 21 · Semua jantina · Dikemas kini 31 Ogo 2026 · NCT04881240CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
Mengambil pesertaFasa 1
Sehingga umur 21 · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07257419Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.